Consistency as tool to support in vitro batch potency testing in GMP production.

Area of Science:

• Veterinary immunology
• Vaccine manufacturing
• Biopharmaceutical quality control

Background:

• Current veterinary vaccine release relies heavily on in vivo testing, which is time-consuming and costly.
• There is a growing need to replace, reduce, and refine animal testing in vaccine production, aligning with the 3Rs principles.
• Ensuring vaccine consistency and quality is paramount for animal health and regulatory compliance.

Purpose of the Study:

• To explore the transition from in vivo release testing to alternative methods in veterinary vaccine manufacturing.
• To outline a strategy for manufacturers to enhance vaccine quality and reduce reliance on animal-based tests.
• To discuss the integration of Good Manufacturing Practice (GMP) and statistical process control for improved consistency.

Main Methods:

• Overview of Good Manufacturing Practice (GMP) principles relevant to vaccine production.
• Explanation of the consistency approach in manufacturing processes.
• Application of statistical analysis to monitor and control critical stages: starting materials, antigen, and finished product.

Main Results:

• The consistency approach, supported by GMP and statistical analysis, allows for building quality into the manufacturing process.
• Implementing these controls at each production stage can significantly reduce the necessity for in vivo finished product testing.
• This integrated strategy aims to improve testing efficiency and product reliability.

Conclusions:

• Moving away from in vivo release tests is feasible through a robust consistency approach and GMP.
• Statistical process control is key to demonstrating and maintaining product quality throughout manufacturing.
• Challenges remain in the widespread adoption of these alternative methods, requiring further development and regulatory acceptance.